Patents by Inventor Kenny Mikael Hansson

Kenny Mikael Hansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating thereto
    Patent number: 11866475
    Abstract: The disclosure relates to modified RNA molecules encoding VEGF-A polypeptides and formulations comprising the modified RNA. Aspects of the disclosure further relate to preparations and uses of formulations comprising the modified RNA in treating subjects suffering from diseases responsive to VEGF-A therapy.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: January 9, 2024
    Assignee: ModernaTX, Inc.
    Inventors: Leif Karlsson Parinder, Regina Desirée Fritsche Danielson, Kenny Mikael Hansson, Li Ming Gan, Jonathan Clarke, Ann-Charlotte Eva Egnell, Kenneth Randall Chien
  • Lipid nanoparticles for delivering modified RNA encoding a VEGF-A polypeptide
    Patent number: 11696892
    Abstract: The disclosure relates to nanoparticles comprising a lipid component and a modified RNA encoding a VEGF-A polypeptide. Aspects of the disclosure further relate to uses of nanoparticles comprising a lipid component and a modified RNA encoding a VEGF-A polypeptide, for improving wound healing in a subject.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: July 11, 2023
    Assignee: ModernaTX, Inc.
    Inventors: Kenny Mikael Hansson, Kerry Benenato, Maria Wågberg, Annika Pålsson, Regina Fritsche-Danielson
  • COMPOSITIONS FOR SKIN AND WOUNDS AND METHODS OF USE THEREOF
    Publication number: 20220226438
    Abstract: This disclosure relates to mRNA therapy for (i) the promotion and/or improvement of wound healing, (ii) the prevention and/or reduction of scar formation at a wound, (iii) the reduction of the visibility of a scar, and/or (iv) the treatment of epidermolysis bullosa. mRNAs for use in the invention, when intradermally (e.g., using microneedles) or topically administered in vivo, encode a wound healing polypeptide (e.g., a growth factor, a cytokine, a chemokine, a protease inhibitor, or a collagen).
    Type: Application
    Filed: May 8, 2020
    Publication date: July 21, 2022
    Applicant: AstraZeneca AB
    Inventors: Kenny Mikael Hansson, Maria Wågberg, Nils Bergenhem
  • METHODS OF USING LIPID NANOPARTICLES FOR DELIVERING MODIFIED RNA ENCODING A VEGF-A POLYPEPTIDE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
    Publication number: 20220226243
    Abstract: The disclosure relates to nanoparticles comprising a lipid component and a modified RNA encoding a VEGF-A polypeptide. Aspects of the disclosure further relate to uses of nanoparticles comprising a lipid component and a modified RNA encoding a VEGF-A polypeptide, for improving wound healing in a subject. Some aspects of the disclosure relate to the topical administration of nanoparticles comprising a lipid component and a modified RNA.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 21, 2022
    Applicant: AstraZeneca AB
    Inventors: Kenny Mikael Hansson, Maria Wågberg, Nils Bergenhem
  • MODIFIED RNA ENCODING VEGF-A POLYPEPTIDES, FORMULATIONS, AND USES RELATING THERETO
    Publication number: 20200407411
    Abstract: The disclosure relates to modified RNA molecules encoding VEGF-A polypeptides and formulations comprising the modified RNA. Aspects of the disclosure further relate to preparations and uses of formulations comprising the modified RNA in treating subjects suffering from diseases responsive to VEGF-A therapy.
    Type: Application
    Filed: June 6, 2017
    Publication date: December 31, 2020
    Applicant: MODERNATX, INC
    Inventors: Leif Karlsson PARINDER, Regina Desirée FRITSCHE DANIELSON, Kenny Mikael HANSSON, Li Ming GAN, Jonathan CLARKE, Ann-Charlotte Eva EGNELL, Kenneth Randall CHIEN
  • LIPID NANOPARTICLES FOR DELIVERING MODIFIED RNA ENCODING A VEGF-A POLYPEPTIDE
    Publication number: 20200338004
    Abstract: The disclosure relates to nanoparticles comprising a lipid component and a modified RNA encoding a VEGF-A polypeptide. Aspects of the disclosure further relate to uses of nanoparticles comprising a lipid component and a modified RNA encoding a VEGF-A polypeptide, for improving wound healing in a subject.
    Type: Application
    Filed: October 31, 2018
    Publication date: October 29, 2020
    Applicant: MODERNATX, INC.
    Inventors: Kenny Mikael Hansson, Kerry Benenato, Maria Wågberg, Annika Pålsson, Regina Fritsche-Danielson